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Abstract: Morphological, functional, and gene expression studies have established the phenotypic plasticity of smooth muscle cells
(SMCs). These cells have been shown to respond to environmental stimulants such as extracellular matrix and growth factors. Cellular
changes can vary between extremes defined as the contractile and synthetic states. Various growth factors have been shown to have
profound effects on the phenotype of these cells. In this study, we intended to investigate the effects of growth factor-rich medium on
the protein expression of vascular SMCs in culture. Interestingly, transiently changing the type of medium did not result in any apparent
morphological differences, yet we hypothesized that some cellular factors might still be altered. In order to understand what kind of
intracellular molecular changes should be expected to occur during the medium change, we analyzed global protein expression changes
using nano-LC-MS/MS in smooth muscle cell cultures that were isolated and grown in one medium formulation and temporarily
switched to the other. Our data indicate that proteins playing a role in energy metabolism (glycolysis), translation, and folding of
proteins are affected, along with regulatory molecules and cytoskeletal proteins. The individual proteins and their significance are
discussed within the scope of this paper.
Key words: Thoracic aortic aneurysm, label-free LC-MS, smooth muscle cell, pathway analysis, smooth muscle cell growth medium,
DMEM/F12 growth medium

1. Introduction
Cell culture has been one of the most popular methods
for researchers studying mammalian systems since its
establishment in the mid-1900s (1). It is a complicated
task, and cells must be maintained under certain growth
conditions such as temperature, humidity, CO2 content,
well-adjusted salt concentrations, optimum pH, and the
presence of growth factors (2). Today, many of these factors
have been well established and it has become routine to
keep most cell contents under these controlled settings.
However, one of the critical issues regarding cell culture
maintenance that constantly evolve is the formulation of
media, whose requirements vary greatly for different cell
types. This is especially difficult with primary cells (2).
Mature vascular smooth muscle cells (SMCs) are able
to undergo transition from a quiescent, contractile state
to a synthetic, proliferative form (3). Differentiated SMCs
express a group of cytosolic and membrane proteins that
are necessary for contractile function (4). Various factors
and diseases such as atherosclerosis, restenosis, and
hypertension cause the cells to dedifferentiate into a highly
* Correspondence: ceyda.acilan@tubitak.gov.tr
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synthetic phenotype (5). Such phenotypic modulation
has recently been reported in aortic aneurysms (6).
Furthermore, many studies report that there is a continuum
from the contractile stage to the more proliferative stage,
and cells quickly adapt the synthetic phenotype in cell
culture (7). A wide range of signaling factors have been
implicated in the transition between these 2 stages,
including basic fibroblast growth factor (bFGF), insulinlike growth factors (IGFs), platelet-derived growth factor
(PDGF), epidermal growth factor (EGF), angiotensinII, α-thrombin, factor Xa, endothelin-1, unsaturated
lysophosphatidic acids, and fetal bovine serum (FBS)
(8–13). Hence, a phenotypic change can be expected when
cells are cultured in specific medium formulations and
then switched to another.
There have been several reports studying vascular SMCs
that were grown in different types of media ranging from
regular media such as M199 (14,15), DMEM (16–18), or
DMEM/F12 (19) supplemented with FBS, with or without
the addition of the above mentioned growth factors, or
commercially available media specially optimized for the
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growth of SMCs (20–23). While the optimized media
appear valuable in terms of being successful in establishing
new primary cell lines and being able to passage longer,
they are not cost-effective. Given the variability for the
choice of media, it is also hard to cross-compare results
from different laboratories. Furthermore, switching from
one formulation to another between experiments (14,19)
for several purposes can also lead to changes that may
interfere with the problem under study.
In order to understand what kind of changes should be
anticipated by shifting growth conditions, we used SMCs
isolated from human aorta and grown in enriched or poor
medium formulations (medium with or without growth
factors) from the day of isolation and then switched to
the other medium for 72 h. We observed the effect of
changing medium conditions in both of these samples
by analysis of global proteomic changes via nano-liquid
chromatography–tandem mass spectrometry (LC-MS/
MS). The hypothesis was that cells grown in identical media
would exhibit similar proteomes. As expected, we found
that switching media resulted in changes in the global
proteome. Among the identified proteins, the expression
of more than 100 proteins was significantly altered after
the medium shift. Within these, 43 proteins were common
in the 2 study groups. To our surprise, both the direction
of the change (upregulation or downregulation) and the
fold change were parallel regardless of whether the change
was to the enriched or to the poor medium conditions. We
concluded that cells adapt to environmental changes by
changing the proteome and similar proteins are effectuated
during this adaptation, yet the effect appears to be a result
of the environmental change itself, rather than a response
to the particular medium used.
2. Materials and methods
2.1. Cell culture
SMCs were either thoracic aortic tissue samples from
patients undergoing aneurysm surgery or coronary bypass
surgery, as described previously (24,25), or were purchased
commercially (Cell Applications, Inc., 354-05a). The tissue
samples were collected and SMCs were isolated on the
same day the surgery was performed. The tissues were kept
in phosphate buffered saline (PBS) solution with penicillin
(10,000 U/mL, streptomycin 10 mg/mL) until isolation of
cells. After the adventitia and endothelial layer of the vessel
were removed, the tissue (~2 mm2) was kept at 5% CO2, 37
°C, for 0.5–1 h on gelatin-coated plates for attachment before
the addition of culture medium. The medium (DMEM/
F12 (Sigma, D0547) + 10% FBS (Biochrome, S0115)) was
changed every 2 to 3 days, and cells were passaged once
approximately 70%–80% confluency was reached. Cells
were maintained in this formulation of medium and were
switched to enriched human aortic smooth muscle cell

growth medium (SMC-GM, Cell Applications, Inc., 311K)
for 72 h, and were then lysed as described below. Cells
that were purchased commercially were isolated by the
company, grown in an enriched medium, and switched to
poor growth conditions (DMEM/F12 + 10% FBS) for 72
h before lysates were prepared. The complete formulation
for DMEM/F12 can be found on the Sigma company
website, but the formulation for SMC-GM is proprietary.
Cell Applications has kindly agreed to partially disclose
the ingredients within the growth medium supplement
as FBS, rhEGF, rhbFGF/heparin, and insulin. The growth
medium also contained 1 g/L glucose and no oxalates.
2.2. Immunohistochemistry staining
SMCs were characterized with α-SMC-actin. Cells were
seeded on sterile 18-mm cover slips and grown in culture
for 48 h. For fixation, cells were incubated in ice-cold
methanol for 10 min at –20 °C. Cells were then washed with
PBS and stored until staining at 4 °C in PBS. Staining was
performed similarly to the protocol used by Akkoyunlu
et al. (26). A ready-to-use detection system was used for
immunohistochemistry (UltraVision Anti-Polyvalent,
HRP, Thermo Scientific). Initially, the cells were incubated
with H2O2 at room temperature (RT) for 10–15 min to
block endogenous peroxidase activity. This was followed
by incubation in blocking solution for 5 min at RT to block
nonspecific binding (Thermo Scientific Ultra V Block). The
polyclonal primary antibodies (α-actin, Abcam, ab5694)
were subsequently added and the slides were incubated
for 30 min (1:100 in PBS). Color formation was achieved
by adding diaminobenzidine (DAB) chromogen and DAB
substrate mixture (RT, 5–10 min) and the cells’ nuclei were
visualized by staining with Mayer’s hematoxylin.
2.3. Sample preparation
Sample preparation was done according to an earlier
published protocol (27). Cultured cells were collected
with HyQtase (Hyclone, SV3003001) treatment and
later washed twice with 50 mM ice-cold ammonium
bicarbonate. Cells were pelleted by centrifugation at 1200
rpm and frozen at –80 °C until LC-MS analysis. Next, 100
µL of 0.1% RapiGest (Waters Corp.), an MS-compatible
detergent (in 50 mM AmBic), was added to the frozen
cells containing a protease inhibitor cocktail and lysed by
ultrasonication (10 s on, 10 s off, for 3 cycles). Cell debris
was removed via centrifugation at 14000 × g and the
supernatant was collected. Sample desalting was done by
washing the protein mixture with 50 mM Ambic in 5-kDa
cut-off spin columns (Vivaspin, Sartorius). Next, 50 µg of
protein from each sample measured with the Bradford
method was transferred to an Eppendorf vial and alkylated
with iodoacetamide (10 mM, 30 min of incubation in
the dark at RT) following disulfite bond reduction with
dithiothreitol (5 mM, 15 min of incubation at 60 °C).
Tryptic peptides were generated with incubation of the
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protein mixture with proteomics-grade trypsin (1:100
protein-to-trypsin ratio) at 37 °C overnight.
2.4. LC-MS/MS analysis
The parameters for the LC-MS analysis were optimized
previously (27). A tryptic peptide mixture was spiked with
50 fmol MassPREP Enolase Digestion Standard (Waters
Corp.). Three technical replicate analyses were performed
for each biological sample, and a 2-µL volume of sample
containing 500 ng of tryptic peptide was loaded onto the
LC-ESI-qTOF system (nanoACQUITY ultrapressure liquid
chromatography (UPLC) and SYNAPT high-definition
mass spectrometer with NanoLockSpray ion source,
Waters)). Columns were equilibrated with 97% mobile phase
A (H2O, 0.1% FA) and 3% mobile phase B (ACN, 0.1% FA).
The column temperature was set to 35 °C. Peptides were
trapped on a nanoACQUITY UPLC Symmetry C18 trap
column (5 µm particle size, 180 µm i.d. × 20 mm length) at
a flow rate of 5 µL/min for 5 min. Peptides were then eluted
from the trap column by gradient elution onto an analytical
column (nanoACQUITY UPLC BEH C18 Column, 1.7
µm particle size, 75 µm i.d. × 250 mm length, Waters) at a
flow rate of 300 nL/min with a linear gradient from 5% to
40% acetonitrile over 90 min. Parallel collusion-induced
dissociation (MSE) was done at positive ion V mode,
applying the MS and MS/MS functions over 1.5-s intervals
with 6-V low energy and high-energy collusions of 15–40
V. Mass drift was corrected by infusing glu-fibrinopeptide
(500 pmol/µL) every 45 s through the NanoLockSpray ion
source at a flow rate of 300 nL/min. Peptide signal data
between 50 and 1600 m/z were collected.
2.5. LC-MS/MS data processing
Data processing parameters were the default values for
the SYNAPT system (27). Peptide mass measurement was
performed at low collusion energy and peptide sequence
data collection at higher collusion energies. Tandem
mass spectra extraction, charge state deconvolution, and
deisotoping were processed with ProteinLynx Global
Server v 2.3 software (PLGS) (Waters Corp.). The protein
sequence database from UniProt was used. The amino
acid sequence of the internal standard (yeast alcohol
dehydrogenase, UniProt accession no. P00330) was
included in the database.
The Apex3D data preparation parameters were set to
0.2 min chromatographic peak width, 10,000 MS TOF
resolution, 150 counts for low energy threshold, 50 counts
for elevated energy threshold, and 1200 counts for the
intensity threshold. The databank search query was set
to a minimum of 3 fragment ion matches per peptide,
minimum 7 fragment ion matches per protein, minimum
1 peptide match per protein, and 1 missed cleavage.
Carbamidomethyl-cysteine fixed modification and acetyl
N-terminal, deamidation of asparagine and glutamine,
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and oxidation of methionine variable modifications were
set. Absolute quantification of the peptides was calculated
with the Hi3 functionality of the IDENTITYE system using
the spiked known amount of the internal standard (28–
30). The false positive rate of the IDENTITYE algorithm
is around 3%–4% (31) with a randomized database and is
5 times larger than the original one (32). The quantitative
analysis is based on the identified proteins, which are
detected in 2 out of the 3 technical replicate injections.
Normalization of the proteins was achieved against the
digest of the internal calibrant P00330. The acquired
protein fold changes were used in the IPA analysis (IPA
version 8.5). The canonical pathways used to construct
the protein–protein interaction map were generated with
protein identifications having a P-value of <0.05 and
greater than 40% expression change.
3. Results
3.1. Sample characterization and morphology
In order to understand the effect of switching medium
formulations on the SMC proteome, we extracted SMCs
from the thoracic region of the aorta and maintained the
cells in the same medium formulation until the day of the
experiment. A total of 4 SMC cultures were used in this
study: while 2 of the cultures were kept in DMEM Nutrient
Mixture F-12 (DMEM/F-12) medium supplemented with
10% FBS from the first day of isolation, 2 others were
established and maintained in an optimized smooth
muscle cell growth medium (SMC-GM, Cell Applications,
Inc.). Due to the small size of the sample obtained, we
could not divide the tissue sample into 2 to obtain cell
cultures from the same origin grown in different medium
formulations from the beginning. However, the differences
due to different cell origins are less likely to be significant
as each sample (lysate from cells after medium change) is
compared to its own origin (lysate from cells always kept
in the original medium).
The cells were tested for smooth muscle α-actin
positivity (>95%) to confirm smooth muscle origin
(Figure 1) and were used for proteomic studies between
passages 3–8 (3 and 7 versus 4 and 8). The mean age of all
individuals from which the cells were isolated was similar
(53 and 58 versus 48 and 54 years). The subjects were all
males except for one.
Interestingly, cells did not adapt to a different
morphology even though they were switched to a
completely different formulation for 72 h. Hence, transient
medium changes may not alter basic cellular characteristics
such as size, shape, or structure (Figure 2).
3.2. Label-free LC-MS/MS and data quality
Once cells reached a sufficient number to continue with
proteomic analysis (approximately 500,000 cells) and
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10X
B

5X

5X

10X

10X
Secondary antibody only

Smooth muscle cell α-actin

Figure 1. A) Images of smooth muscle cells extracted from
aortic tissue. Image was taken with a phase contrast filter (10×
magnification). B) Cells were characterized by α-actin positivity
for smooth muscle origin. Images were taken with a bright field
filter (5× and 10× magnification as indicated).

a confluence of 70%–80%, the medium was switched to
DMEM/F12 if cells were regularly kept in SMC-GM, or to
SMC-GM if cells were regularly kept in DMEM/F12. Cells
were maintained in the new medium for 72 h and were lysed
and used in LC-MS/MS analyses as described in Section 2.
Tryptic peptides generated from SMCs were qualitatively
and quantitatively analyzed with label-free nano-LC-MS/
MS methodology. Peptide separation was performed on
nanoACQUITY UPLC and peptide m/z measurement
and sequencing were performed on a SYNAPT HDMS
mass spectrometer. The quantitative rigor of the peptide
measurement was evaluated based on 3 technical replicates.
A triplicate injection of the control sample followed by the
calculation of the standard deviations of the quantitative
values for each protein provided the variation in the
measurements. The intensity coefficient of variation (CV),
expressed as %CV intensity, averaged below 16% across all
the identified peptides. The accuracy of the peptide massto-charge ratio of the identified peptides was evaluated
and the calculated average mass error for the precursors
was shown to be below 5 ppm. Label-free analysis was
based on the reproducibility of peptide elution times on
nanochromatography instruments. The chromatographic
retention time coefficient of variation, calculated as %CV
RT, averaged below 0.5%, providing very reproducible
peptide elutions for comparative analysis.

DMEM/F-12

SMC-GM

SMC-GM

DMEM/F-12

Figure 2. Cell morphology before and after change of medium: left column indicates
the morphology in medium in which cells were extracted and never prone to medium
change. The right column indicates the morphology after medium change. DMEM/F-12:
Dulbecco’s Modified Eagle Medium/Nutrient Mixture F-12; SMC-GM: Smooth Muscle
Cell Growth Medium. Phase contrast microscopy, 10× magnification.
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3.3. The effect of medium change on the smooth muscle
cell proteome
Applying the identification criteria discussed in Section 2,
a total of 379 proteins were identified when the medium
was shifted from SMC-GM to DMEM/F12, and 294
proteins were identified when the medium was changed
from DMEM/F12 to SMC-GM. Utilizing PLGS, the
expressions of more than 100 proteins were significantly
altered in each experiment. Two additional elimination
criteria were applied: first, based on PLGS identification
score (a score below 100 was considered unreliable after a
manual reevaluation of their protein spectra), and second,
based on fold change (intensity cut-off was set to 40% and
only the proteins that were up- or downregulated by more
than the 40% cut-off were reported). When these limiting
criteria were followed, 8 (SMC-GM → DMEM/F12) and 29
(DMEM/F12 → SMC-GM) of the differentially expressed
proteins were further eliminated, still leaving about 100
proteins that were significantly differentially expressed. A
summary is given in Table 1.
Interestingly, 43 of the approximately 100 proteins that
were found to be significant were the same on both lists.
Forty of the 43 proteins were downregulated in response to
changing the medium, while only 3 of 43 were upregulated
in 1 medium and downregulated in the other. Since these
43 proteins were identified on both lists, we decided to
focus on these common proteins in order to understand
the effect of medium change on SMCs. The complete list
and categorization of these proteins is shown in Table 2.
3.4. Ingenuity Pathway Analysis
Based on their function, the 43 proteins were grouped
as ones that play a role in energy metabolism (mainly
glycolysis), that play a role in protein folding, that play a
role in translation of proteins, that are regulatory, that are
structural cytoskeleton proteins, or that belong to annexin
family, as well as 3 others that do not fall into these
categories. In order to understand how these proteins are
associated with each other as well as with other signal
transduction pathways, the data were further analyzed
using Ingenuity Pathway Analysis (IPA version 8.5)
software, which is a knowledge-based database containing
biological interactions and functional annotations created
from millions of modeled relationships between different
types of biological samples and molecules. Interestingly,
more than half of these proteins (23/43) were merged

into a single network, with a score of 61 (Figure 3). A
score of ≥2 is significant; the score indicates the log of
the probability of network eligible proteins appearing
in a network by random chance. The higher the score is,
the lower the probability of randomness. The complete
list of networks and scores is given in Table 3. Consistent
with our manual protein characterization analysis based
on function, IPA analysis showed that the top canonical
pathway was the glycolysis/gluconeogenesis pathway (P
= 2.5 × 10–9), which was followed by the 14-3-3 mediated
signaling pathway (P = 1.37 × 10–5). The top 10 canonical
pathways and biological functions are given in Figure 4.
4. Discussion
It is well known that change in environmental conditions
may affect both the morphology and the differentiation
state of cells (33–35). Not only the composition of the
medium but also the replacement of culture media has
been shown to affect gene expression in a periodic wave on
differentiating cells (36). On the other hand, some other
cell types appear to be less affected by such modifications,
where medium change had been reported to have neither
favorable nor harmful consequences on the development
when cultured in different media, indicating that some
factors have less impact on various cellular properties
(37). Indeed, fewer changes are expected to occur when
cells are already finally differentiated. The change will also
probably be cell type-specific, and the response may be
different when different cells are under study. Hence, there
still remains a question as to what kind of intracellular
molecular changes occur within the cells after changing
the culture medium.
In this study, we wished to focus on vascular SMCs as
they are frequently used as a model system in the study of
cardiovascular diseases and there is a need for switching
from one medium to another as a result of experimental
protocols. In order to determine the impact of medium
change on SMCs, we performed a label-free nano-LC-MS/
MS analysis and examined the changes in the proteome.
Before the analysis was performed, our hypothesis was that
cells would behave similarly given that they are grown in
the same medium. The expectation was that shifting from
one medium to the other, i.e. from SMC-GM to DMEM/
F12, would drive the cells to have similar proteome
profiles as the ones that were always grown in DMEM/F12.

Table 1. Number of proteins identified.
Medium change

Total proteins identified

Proteins with significantly
altered expression

Proteins with PLGS
score of >100

Number of proteins
common in both lists

SMC-GM → DMEM/F12

379

110

104

43

DMEM/F12 → SMC-GM

294

132

113
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Table 2. List and function of proteins that appear to be significantly altered on both lists. The direction of the arrow indicates whether the
expression of the protein is up- or downregulated. Three arrows indicate unique proteins; 2 arrows indicate proteins whose expression
is changed more than 5-fold. Note: The functions may include information from protein databases such as UniProt.
Accession

Description

Regulation

Function

Energy metabolism
P00338

LDHA: L lactate dehydrogenase A chain

↓

P07195

LDHB: L lactate dehydrogenase B chain

↓

P14618

KPYM: Pyruvate kinase isozymes

↓

P04406
P18669

G3P: Glyceraldehyde 3 phosphate
dehydrogenase
PGAM1: Phosphoglycerate mutase 1

Catalyzes the conversion of L-lactate and NAD+ to
pyruvate and NADH in the final step of anaerobic
glycolysis
Catalyzes the interconversion of pyruvate and lactate
with concomitant interconversion of NADH and
NAD+
Glycolytic enzyme that catalyzes the transfer of a
phosphoryl group from phosphoenolpyruvate (PEP) to
ADP, generating ATP
Plays a general role in caspase-independent cell death
of tumor cells

↓↓

Catalyzes step 6 of glycolysis

↓

Catalyzes step 8 of glycolysis

P06733

ENOA: Alpha enolase

↓

A glycolytic enzyme expressed in most tissues, one of
the isozymes of enolase
Encodes the Myc-binding protein-1(MBP1), which
downregulates the activity of c-myc
Plays a part in processes such as growth control,
hypoxia tolerance, and allergic responses
May also function in the intravascular and pericellular
fibrinolytic system due to its ability to serve as a
receptor and activator of plasminogen on the cell
surface of several cell types such as leukocytes and
neurons; stimulates immunoglobulin production

P60174

TPIS: Triosephosphate isomerase

↓

Catalyzes the reversible interconversion of the triose
phosphate isomers dihydroxyacetone phosphate and
D-glyceraldehyde 3-phosphate

↓↓↓

Generation of nicotinamide adenine dinucleotide
phosphate (reduced NADPH), for reductive
biosynthesis
Formation of ribose, which is an essential component
of ATP, DNA, and RNA
Transaldolase links the pentose phosphate pathway to
glycolysis

P37837

TALDO: Transaldolase

Protein folding
P07237

PDIA1: Protein disulfide isomerase

↓

P30101

PDIA3: Protein disulfide isomerase A3

↓

Q15084

PDIA6: Protein disulfide isomerase A6

↓

Catalyzes the formation and breakage of disulfide
bonds between cysteine residues within proteins as
they fold
Catalyzes the formation and breakage of disulfide
bonds between cysteine residues within proteins as
they fold
May function as a chaperone that inhibits aggregation
of misfolded proteins
Plays a role in platelet aggregation and activation by
agonists such as convulxin, collagen, and thrombin
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Table 2. (continued).
Q8NBS9

TXND5: Thioredoxin domain containing
protein 5

↓

P14625

ENPL: Endoplasmin

↓

P50454

SERPH: Serpin H1

↓

P08238

HS90B: Heat shock protein HSP 90 beta

↓

A protein disulfide-isomerase; its expression is induced
by hypoxia
Its role may be to protect hypoxic cells from apoptosis
Molecular chaperone that functions in the processing
and transport of secreted proteins; has ATPase activity
Serpin peptidase inhibitor, clade H (heat shock protein
47), member 1,
human chaperone protein for collagen

P27797

CALR: Calreticulin

↓

Multifunctional protein that binds Ca2+ ions, rendering
them inactive
Binds to misfolded proteins and prevents them from
being exported
from the endoplasmic reticulum to the Golgi apparatus

P62988

UBIQ: Ubiquitin

↓↓

Binds to proteins and labels them for destruction

Cytoskeleton
Actin cytoskeleton
P60709

ACTB: Actin cytoplasmic 1

↓↑

P26038

MOES: Moesin

↓

P07737

PROF1: Profilin

↓↓

Q562R1

ACTBL: Beta-actin-like protein 2

↑

Highly conserved proteins that are involved in various
types of cell motility
Probably involved in connections of major cytoskeletal
structures to the plasma membrane
Regulates actin polymerization in response to
extracellular signals
Beta-actins coexist in most cell types as components
of the cytoskeleton and as mediators of internal cell
motility

Tubulin cytoskeleton
P07437

TBB5: Tubulin beta chain

↓

Major constituent of microtubules

Q13748

TBA3C: Tubulin alpha 3C D chain

↓↓↓

P68363

TBA1B: Tubulin alpha 1B chain OS

↓

One of the alpha tubulin genes
Tubulin binds 2 moles of GTP, 1 at an exchangeable
site on the beta chain

Intermediate filaments

P04264

K2C1 Keratin type II cytoskeletal 1

↓↓↓

P17661

DESM Desmin

↓

P41219

PERI Peripherin

↓

May regulate the activity of kinases such as PKC
and SRC via binding to integrin beta-1 (ITB1) and
the receptor of activated protein kinase C (RACK1/
GNB2L1).
type III intermediate filament found near the Z line in
sarcomeres
a type III Intermediate filament (IF) protein expressed
mainly in neurons

Translation
P62424

RL7A: 60S ribosomal protein L7a

↓↑

One of the proteins in the 60S large subunit of the
eukaryotic ribosome

P05387

RLA2: 60S acidic ribosomal protein P2

↓↓↓

A ribosomal phosphoprotein that is a component of
the 60S large subunit
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Table 2. (continued).

P13639

EF2: Elongation factor 2

↓

Catalyzes the GTP-dependent ribosomal translocation
step during translation elongation
Catalyzes the coordinated movement of the 2 tRNA
molecules, the mRNA, and conformational changes in
the ribosome

Q05639

EF1A2: Elongation factor 1 alpha 2

↓

Is responsible for the enzymatic delivery of aminoacyl
tRNAs to the ribosome

P06748

NPM: Nucleophosmin

↓

Is involved in the biogenesis of ribosomes
May assist small basic proteins in their transport to the
nucleolus

P62937

PPIA: Peptidyl prolyl cis trans isomerase A

↓

Catalyzes the interconversion of peptidylprolyl imide
bonds in peptide and protein substrates

Regulatory protein

P62258

P63104

1433E: 14-3-3 protein epsilon

1433Z: 14-3-3 protein zeta delta

↓

Adapter protein implicated in the regulation of a large
spectrum of both general and specialized signaling
pathways
Interacts with CDC25, RAF1, and IRS1, suggesting its
role in diverse biochemical activities related to signal
transduction, such as cell division and regulation of
insulin sensitivity

↓

Adapter protein implicated in the regulation of a large
spectrum of both general and specialized signaling
pathways
Binding generally results in the modulation of the
activity of the binding partner

P09382

LEG1: Galectin

↓

May regulate apoptosis, cell proliferation, and cell
differentiation
Inhibits CD45 protein phosphatase activity and
therefore the dephosphorylation of Lyn kinase
Beta-galactoside-binding protein, modulates cell–cell
and cell–matrix interactions

P06703

S10A6: Protein S100 A6

↓

Involved in the regulation of a number of cellular
processes, such as cell cycle progression and
differentiation

Annexin family

P07355

ANXA2: Annexin A2

↓

Is involved in diverse cellular processes such as cell
motility (especially that of the epithelial cells), linkage
of membrane-associated protein complexes to the actin
cytoskeleton, endocytosis, fibrinolysis, ion channel
formation, and cell matrix interactions
Is a calcium-dependent phospholipid-binding protein
whose function is to help organize exocytosis of
intracellular proteins to the extracellular domain
Annexin II is a pleiotropic protein, meaning that its
function is dependent on place and time in the body

P04083

ANXA1: Annexin A1

↓

May have potential antiinflammatory activity
May act as a tumor suppressor gene and modulate the
proliferative functions of estrogens
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Table 2. (continued).

P08758

ANXA5: Annexin A5

↓

The function of the protein is unknown
Annexin A5 has been proposed to play a role in the
inhibition of blood coagulation by competing for
phosphatidylserine binding sites with prothrombin and
also to inhibit the activity of phospholipase A1

Others
P13489

RINI: Ribonuclease inhibitor

↓

P20962

PTMS: Parathymosin

↓↓↓

Q14192

FHL2: Four and a half LIM domains protein 2

↓↑

Leucine-rich repeat protein that forms extremely tight
complexes with certain ribonucleases
Parathymosin may mediate immune function by
blocking the effect of prothymosin alpha, which
confers resistance to certain opportunistic infections
Inhibits transcriptional activation of vSMC-specific
genes mediated by the bone morphogenetic protein
signaling pathway
May function as a molecular transmitter linking
various signaling pathways to transcriptional
regulation
B IPA legends

Figure 3. A) Most high-scored network (Network 1): pathway generated by IPA with proteins identified as specific target antigens for
the common proteins on both lists in response to changing medium (see text for details). Proteins with no color were not detected by
LC-MS, yet were added to the network by the IPA algorithm. Green indicates downregulation and gray indicates down- or upregulation
(based on the medium change direction). The intensity of the color correlates with the degree of fold change in expression. Note that
most proteins are downregulated and were fitted in a single network. B) IPA legends for path designer shapes and edge types.
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Table 3. The high-scored biological networks in human aortic SMCs in response to medium change. Molecules in bold were identified
in the analysis, while others were added by the software program to create a network.
Network ID

Score

Focus
molecules

61

23

26

12

11

6

Antigen Presentation
Pathway

RhoA Signaling

Lipid Antigen Presentation
by CD1

Gap Junction Signaling

Pyruvate Metabolism

p70S6K Signaling

PI3K/AKT Signaling

9
8
7
6
5
4
3
2
1
0
Glycolysis/
Gluconeogenesis

-log (P-value)

3

ACTBL2, AP2A1, CCDC15, CHD3, EIF6, G6PD, GET4,
Cellular assembly and
HAUS1, HAUS2, HAUS3, HAUS4, HAUS5, HAUS6, HAUS7,
HAUS8, IRF3, MYB, NAA38, PA2G4, PDS5A, PLK4, PRPH, organization, cellular function
PTMS, PXK, RELB, RPLP0, RPLP1, RPLP2, RXRB, TALDO1, and maintenance, cell cycle
TUBG1, TUBG2, TXNDC5, UBC, ZNF24

Hypoxia Signaling in the
Cardiovascular System

2

Top functions

ACTB, Actin, Alpha tubulin, ANXA1, ANXA2, ANXA5,
Beta tubulin, Cofilin, DES, ENO1, F-actin, GAPDH,
Hematological disease,
Immunoglobulin, Ldh, LDHA, LDHB, MSN, NFkB (complex),
immunological disease,
P4HB, PDGF (family), PDIA3, PDIA6, PFN1, PGAM1, PKM2,
inflammatory disease
PPIA, Profilin, RNH1, Rock, S100A6, TPI1, TUBA1B, TUBB,
Tubulin, YWHAZ
26S Proteasome, Akt, Calmodulin, CALR, CD3, Ck2,
Collagen(s), Creb, EEF2, EEF1A2, ERK1/2, FHL2, Histone h3,
Cellular compromise, cellular
Hsp70, Hsp90, HSP, HSP90AB1, HSP90B1, Insulin, Integrin,
function and maintenance,
Jnk, KRT1, LGALS1, MHC class I (complex), NPM1, P38
protein synthesis
MAPK, PI3K (complex), Pkc(s), Ras, RNA polymerase II,
RPL7A, SERPINH1, TCR, Vegf, YWHAE

14-3-3-mediated Signaling

1

Molecules in network

Figure 4. Top canonical pathways. The 43 significant genes identified by LC-MS/
MS were used for the analysis of canonical pathways. The bars represent the various
pathways or functions described on the left of the graph. The height of the bars
indicates the P-values. The yellow boxes indicate # of genes in the list / total # of genes
in the pathway. The yellow line shows the threshold of significance.

Interestingly, the list of differentially expressed proteins
was quite similar: 43 out of approximately 100 proteins
were the same on both lists. Such an overlap is quite
striking, especially when completely independent samples
and different experiments are analyzed. Furthermore,
40/43 of the overlapping proteins had the same direction
of expression change (up- or downregulation). Hence,
contrary to our expectations, our data indicated that the

proteomic differences that we detected were a response to
medium shift per se rather than a proteome profile for the
cells grown in a specific medium.
The presence of growth factors has been shown to
result in protein expression changes in SMCs in several
previous studies (38–40). However, in our study, although
we observed changes, the changes were not in response
to the presence of growth factors. The fact that we failed
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to find alterations specific to a growth medium could be
explained as follows: 1) the changes are not immediate, i.e.
longer incubation times are needed; 2) the altered proteins
are of low abundance; or 3) limitations arose, derived from
our equipment.
Based on our analysis, the glycolytic pathway appeared
to be important with several proteins being differentially
regulated after a medium change. The 2 formulations have
different concentrations of glucose levels (1 g/L in SMC-GM
and 3.15 g/L in DMEM/F12), and hence it is not surprising
that a change is detected. Interestingly, however, switching
to higher glucose levels did not stimulate the glycolytic
pathway. Since most of these proteins are downregulated
in both switches, we interpreted this result as a response
of stalling cellular processes until the cells adapt to new
conditions leading to less need for energetic processes. In
a similar study, the number of medium changes was shown
to affect the proliferation and metabolism of cultured cells
(41). Although in this study we only changed the medium
once (yet to a different formulation), both studies indicate
that factors regarding the metabolism may be a common
denominator as a result of medium change. Indeed, these
suggestions should be verified via functional assays and
additional immunoblotting experiments to strengthen
and draw more rigid conclusions. Interestingly, proteins
involved in translation and protein folding were also
significantly downregulated, suggesting that synthesis and
concurrently folding of new proteins were diminished
in the time frame of the experiment. Reduction in the
synthesis of new proteins can also explain the decreased

requirement for energy production pathways. These 2 data
sets show correlation with each other.
Surprisingly, although there were no apparent alterations
in the morphology of cells after a medium change, our
proteomic analysis revealed that several cytoskeletal proteins
with examples from all types (including actin filament
components, microtubules, and intermediate filaments)
were in fact differentially expressed. This finding is further
proof that molecular changes are not always reflected at
the morphological level. Other identified proteins include
regulatory proteins that function in several signaling
pathways, suggesting the presence of additional expression
changes that we failed to detect. Hence, additional studies
are needed to identify more proteins to have a better
understanding of the effect of medium.
In summary, our results suggest a general
downregulation of proteins in glycolysis and in processes
requiring energy such as protein synthesis and folding.
With these findings, most importantly, we wish to raise
awareness for the type of expression changes that might
occur in response to shifting medium, albeit with no
significant change in morphology, and draw scientists’
attention to the need for careful interpretation of their
results.
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